Latex agglutination test: an effective screening tool for melioidosis diagnosis

Authors

  • Chidchanok Promkong Nakornpanom Hospital

Keywords:

Melioidosis, Burkholderi pseudomallei, latex agglutination, sepsis, diagnosis

Abstract

Previously, the incompetency to speed up the diagnosis process of melioidosis, a fetal infections cause by Burkholderia pseudomallei (Bp), consequently, lower down the survival rate of patients. Here, it is clearly demonstrated that the latex agglutination test can serve as an effective screening method for melioidosis diagnosis. To confirm its effectiveness in term of sensitivity, specificity, positive- predictive value, negative-predictive value and accuracy by latex agglutination test, specimen samples including blood, pus, sputum, urine and body fluid were collected from Nakhon Phanom Hospital in northeast Thailand during October 2015 to August 2017 for statistical analysis. Then, bacteria were cultured from the hospital collected specimens, and the bacterial colonies were primarily screened for their (+) oxidase producing and non-lactose fermentative properties. Accordingly, bacterial culture from 637 clinical specimens which were found to be positive for those two criteria, were included for an accuracy assessment of the latex agglutination test in comparison to the goal standard biochemical identification method. Statistical analysis revealed that a sign of melioidosis are able to be detected in 401 hemoculture sample by the latex agglutination with 100% sensitivity, 96.7% specificity, 99.4% positive-predictive value and 100% negative-predictive value. Moreover, melioidosis could be rapidly diagnosed for 236 other non-hemoculture samples with 100% accuracy by latex agglutination test. Timing for latex agglutination test was found to be significantly shorter than that of the standard method. Thus, it implied that this timeminimising test can serve as an effective alternative tool for melioidosis diagnosis.

References

Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. Apr;18(2):383-416.

Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB, et al. 2018. Melioidosis. Nat Rev Dis Primers. Feb 1;4:17107.

Currie BJ, Ward L, Cheng AC. 2010. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. Nov 30;4(11):e900.

Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, et al. 2010. Increasing incidence of human melioidosisin Northeast Thailand. Am J Trop Med Hyg. Jun;82(6):1113-7.

Lau SK, Sridhar S, Ho CC, Chow WN, Lee KC, Lam CW, et al. 2015. Laboratory diagnosis of melioidosis: past, present and future. Exp Biol Med (Maywood). Jun;240(6):742-51.

Inglis TJ. 2010. The Treatment of Melioidosis.Pharmaceuticals (Basel). Apr 27;3(5):1296-303.

Wiersinga WJ, Currie BJ, Peacock SJ. 2012. Melioidosis. N Engl J Med. Sep 13;367 (11):1035-44.

Opota O, Croxatto A, Prod'hom G, Greub G. 2015. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect. Apr;21(4):313-22.

Limmathurotsakul D, Wuthiekanun V, Wongsuvan G, Pangmee S, Amornchai P, Teparrakkul P, et al. 2011. Repeat blood culture positive for B. pseudomallei indicates an increased risk of death from melioidosis. Am J Trop Med Hyg. Jun;84(6):858-61.

Cheng AC, O'Brien M, Freeman K, Lum G, Currie BJ. 2006. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg. Feb;74(2):330-4.

Tiyawisutsri R, Peacock SJ, Langa S, Limmathurotsakul D, Cheng AC, Chierakul W, et al. 2005. Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutination assay. J Clin Microbiol. Sep;43(9):4872-4.

Suttisunhakul V, Chantratita N, Wikraiphat C, Wuthiekanun V, Douglas Z, Day NP, et al. 2015. Evaluation of polysaccharide-based latex agglutination assays for the rapid detection of antibodies to Burkholderia pseudomallei. Am J Trop Med Hyg. Sep;93(3):542-6.

Kaestli M, Richardson LJ, Colman RE, Tuanyok A, Price EP, Bowers JR, et al. 2012. Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol. Jun;50(6):2059-62.

Mathai E, Jesudason MV, Anbarasu A. 2003. Indirect immunofluorescent antibody test for the rapid diagnosis of melioidosis. Indian J Med Res. Aug;118: 68-70.

Houghton RL, Reed DE, Hubbard MA, Dillon MJ, Chen H, Currie BJ, et al. 2014. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis. Mar;8(3):e2727.

Pumpuang A, Dunachie SJ, Phokrai P, Jenjaroen K, Sintiprungrat K, Boonsilp S, et al. 2017. Comparison of O-polysaccharide and hemolysin co-regulated protein as target antigens for serodiagnosis of melioidosis. PLoS Negl Trop Dis. Mar;11(3):e0005499.

Suttisunhakul V, Wuthiekanun V, Brett PJ, Khusmith S, Day NP, Burtnick MN, et al. 2016. Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei. J Clin Microbiol. May;54(5):1259-68.

Chuah SC, Gilmore G, Norton RE. 2005. Rapid serological diagnosis of melioidosis: an evaluation of a prototype immunochromatographic test. Pathology. Apr;37(2):169-71.

O'Brien M, Freeman K, Lum G, Cheng AC, Jacups SP, Currie BJ. 2004. Further evaluation of a rapid diagnostic test for melioidosis in an area of endemicity. J Clin Microbiol. May;42(5):2239-40.

Kohler C, Dunachie SJ, Muller E, Kohler A, Jenjaroen K, Teparrukkul P, et al. 2016. Rapid and Sensitive Multiplex Detection of Burkholderia pseudomallei-Specific Antibodies in Melioidosis Patients Based on a Protein Microarray Approach. PLoS Negl Trop Dis. Jul;10(7):e0004847.

Duval BD, Elrod MG, Gee JE, Chantratita N, Tandhavanant S, Limmathurotsakul D, et al. 2014. Evaluation of a latex agglutinationassay for the identification of Burkholderia pseudomallei and Burkholderia mallei. Am J Trop Med Hyg. Jun;90(6):1043-6.

Anuntagool N, Naigowit P, Petkanchanapong V, Aramsri P, Panichakul T, Sirisinha S. 2000. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol.Dec; 49(12):1075-8.

Simundic AM. 2009. Measures of Diagnostic Accuracy: Basic Definitions. EJIFCC. Jan;19(4):203-11.

Hoffmaster AR, AuCoin D, Baccam P, Baggett HC, Baird R, Bhengsri S, et al. 2013. Melioidosis diagnostic workshop, Emerg Infect Dis. Feb;21(2).

White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. 1989. Halving of mortality of severe melioidosis by ceftazidime. Lancet. Sep 23;2(8665): 697-701.

Tiangpitayakorn C, Songsivilai S, Piyasangthong N, Dharakul T. 1997. Speed of detection of Burkholderia pseudomallei in blood cultures and its correlation with the clinical outcome. Am J Trop Med Hyg. Jul;57(1):96-9.

Downloads

Published

2018-07-15

How to Cite

1.
Promkong C. Latex agglutination test: an effective screening tool for melioidosis diagnosis. JODPC10 [internet]. 2018 Jul. 15 [cited 2026 Jan. 4];16(1):38-50. available from: https://he02.tci-thaijo.org/index.php/odpc10ubon/article/view/250558

Issue

Section

Original Articles